Pineapple Financial is no longer primarily a Canadian mortgage brokerage. The current fiscal year converted the listed equity into a concentrated Injective token treasury wrapped around a still-lossy origination franchise. The third-quarter profit is a mark-to-market event, not a brokerage earning-power print. Shareholders now own a leveraged token book first and a sub-scale lender network second. The debate is whether that token book is residual value or a mark that reverses when Injective prices fall.
Management still records substantial doubt about continuing as a going concern even after the token rebound. Nine-month revenue stayed near $2.1 million. Operating cash outflow still exceeded $4.6 million. The January private placement issued roughly twenty-five million shares and stuffed the balance sheet with cash plus tokens. Stated book now sits near $52 million against a mid-September capitalization near $22 million. The discount exists because the auditor resigned in June, the White Lion equity line remains unused, and most of the token stack sits as collateral on a FalconX facility.
The mortgage franchise is not disappearing, but it is not carrying the equity either. Nine-month origination volume held near last year's pace and subscription fees rose, while payroll was cut hard enough to produce a small positive adjusted earnings figure. That operating improvement does not retire the going-concern paragraph. The next several prints resolve whether Injective prices stay above the loan collateral need, whether Davidson and Company keeps the going-concern language, and whether the unused quarter-billion equity line ever becomes a live dilution tap.